ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Microfilament-Myosin II Regulates the Differentiation of Multinucleated Cysts into Oocytes and Influences Oocyte Developmental Potential in Mice.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microfilament-Myosin II Regulates the Differentiation of Multinucleated Cysts into Oocytes and Influences Oocyte Developmental Potential in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Primary oocyte differentiation in females is a complex and selective process; however, its regulatory mechanisms remain poorly understood. In this study, multinucleated cysts are identified as precursors for oocyte differentiation. Disruption of microfilament dynamics disrupts the differentiation of multinucleated cysts into oocytes, resulting in reduced oocyte volume, polarity defects, Balbiani body (B-body) absence, and double-nucleated oocytes. Proteomics analysis reveals that microfilament depolymerization alters the myosin II isoform expression and decreases myosin II activity. Subcellular localization analysis of myosin II in multinucleated cysts demonstrates that myosin IIA co-localized with microfilaments in the cortex and cytoplasm; myosin IIB is associated with the Golgi apparatus; and myosin IIC is distributed diffusely in the cytoplasm. Pharmacological inhibition of myosin II activity or specific knockdown of myosin II isoforms leads to oocyte differentiation abnormalities, including reduced oocyte volume, failed B-body formation, and double-nucleus phenotypes. Compromised differentiation quality of oocytes has long-term consequences, with defective oocytes showing impaired developmental progression, elevated apoptosis, and diminished meiotic competence. These defects are evidenced by reduced rates of germinal vesicle breakdown (GVBD) and first polar body (PB1) excretion, mitochondrial dysfunction, reduced Golgi and endoplasmic reticulum components, and increased spindle abnormalities. In conclusion, this study identifies multinucleated cysts as precursors for oocyte differentiation, highlighting the importance of microfilament myosin II in oocyte differentiation and its long-term influence on oocyte differentiation quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.